[go: up one dir, main page]

Cortesina et al., 1982 - Google Patents

Production of leukocyte migration inhibition factor by lymphocytes of larynx cancer patients stimulated by laryngeal carcinoma solubilized membrane antigens

Cortesina et al., 1982

Document ID
6681294245049454404
Author
Cortesina G
Cavallo G
Beatrice F
Sartoris A
Bussi M
Morra B
Di Fortunato V
Poggio E
Rendine S
Publication year
Publication venue
Tumori Journal

External Links

Snippet

The production of leukocyte migration inhibition factor (LIF) from lymphocytes after stimulation with 3 M KCl soluble tumor and normal mucosa extracts was investigated in 30 patients with laryngeal carcinoma at different development stages and in 30 normal donors …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
MORTON et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine
Rosenberg et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
Springer T and Tn, general carcinoma autoantigens
Springer et al. Tn, a carcinoma‐associated antigen, reacts with anti‐Tn of normal human sera
Beynon et al. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer
Gerfo et al. Tumor associated antigen with pulmonary neoplasms
Mavligit et al. Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen
Han et al. Depression of T lymphocyte response by non‐t suppressor cells in lung cancer patients. A possible prognostic value of suppressor‐cell activity
Mattijssen et al. Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma
Morimoto et al. Studies of Anti‐lymphocyte Antibody of Patients with Active SLE: I. Cause of Loss of Suppressor T‐Lymphocyte Function
Cortesina et al. Production of leukocyte migration inhibition factor by lymphocytes of larynx cancer patients stimulated by laryngeal carcinoma solubilized membrane antigens
Mathieson et al. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis
Gross et al. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease
Igarashi et al. Changes on Distribution of CD4+/CD45RA-and CD87CD1Y Cells in Tumor-Infiltrating Lymphocytes of Renal Cell Carcinoma Associated with Tumor Progression
Bernengo et al. Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course
Holmes Immunology and lung cancer
De Gast et al. Humoral and cell‐mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to pha and antigens following immunization
Chabannon et al. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study
Al-Mondhiry et al. Tumor interaction with vascular endothelium
Krause et al. Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis
Hersey et al. Prognostic significance of leukocyte-dependent antibody activity in melanoma patients
Vanhaelen et al. Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cells.
Puerschel et al. Immunoreactivity of glycoprotein lib is present in metastasized but not in non‐metastasized primary malignant melanoma
Kjaer Effect of leucocyte washings on cellular immunity to human renal carcinoma
Sears et al. Advantages Cryopreserved Lymphocytes for Sequential Evaluation of Human Immune Competence. II. Mixed Lymphocyte Cultures and of Mononuclear Cell Subpopulations